Can NexgenRx Inc.'s (CVE:NXG) Weak Financials Pull The Plug On The Stock's Current Momentum On Its Share Price?
NexgenRx Announces Third Quarter Results and Declaration of Divdend
NexgenRx Inc. Shareholders Convene and Vote
NexgenRx Inc: MDA EN
NexgenRx Inc: AUDITED ANNUAL FINANCIAL STATEMENTS EN
NexgenRx Inc. Announces Q3 2023 Quarterly Results With Continued Revenue Growth and Positive EBITDA
Nexgenrx Announces Q2 2023 Quarterly Results (With Continued Revenue Growth), Consulting Agreement and Option Grant
NexgenRx Inc: INTERIM MDA EN
NexgenRx Inc: INTERIM FINANCIAL STATEMENTSREPORT EN
NexgenRx Announces Declaration of Dividend
NexgenRx Announces Q1 2023 Quarterly Results With Continued Revenue Growth and Positive EBITDA and Announces Election of New Director
NexgenRx Announces 2022 Year End Results With Continued Revenue Growth And Positive EBITDA
Is NexgenRx Inc.'s (CVE:NXG) Recent Stock Performance Tethered To Its Strong Fundamentals?
NexgenRx Inc. Declares $0.005 Dividend
NexgenRx Inc: MD&A - ENGLISH
NexgenRx Inc: AB FORM 13-501F1 (CLASS 1 AND 3B REPORTING ISSUERS - PARTICIPATION FEE)
NexgenRx Inc: AUDITED ANNUAL FINANCIAL STATEMENTS - ENGLISH
NexgenRx Inc: ON FORM 13-502F1 (CLASS 1 AND 3B REPORTING ISSUERS - PARTICIPATION FEE)
No Data